Expanding HPV Vaccination to All Adults Aged 27-45 Years Unlikely to Be Cost-Effective or Efficient for HPV-Related Cancer Prevention
A modeling study projected that HPV vaccination programs for adults aged 27 to 45 years could benefit subgroups at higher risk for HPV, but overall, the approach is more costly…